Xiaotian Dai

831 citations
29 papers · 594 indexed · h-index 13
Topics
Neonatal Respiratory Health Research (5 papers)Mesenchymal stem cell research (3 papers)Sirtuins and Resveratrol in Medicine (3 papers)
Partner nations
ChinaCanadaPakistan

In The Last Decade

Xiaotian Dai

27 papers receiving 590 citations

Peers

Xiaotian Dai
Comparison fields: 5 of 84
  • Molecular Biology 327
  • Pulmonary and Respiratory Medicine 145
  • Cancer Research 117
  • Molecular Medicine 96
  • Oncology 90
Replace Weiqing Wu with:
Weiqing Wu China
Ying-Chao Lin Taiwan
Shaoshan Han China
Adam Gilbertsen United States
Shu Xia China
Oksana Kowalczuk Poland
Shiyun Cui China
Xinying Xue China
Luo Yang China
Xiaotian Dai relative to Weiqing Wu China Weiqing Wu's profile →
Citations per field
00.5×
Weiqing Wu · 1×
Citations per year

Countries citing papers authored by Xiaotian Dai

Since Specialization
Citations

This map shows the geographic impact of Xiaotian Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaotian Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaotian Dai more than expected).

Fields of papers citing papers by Xiaotian Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaotian Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaotian Dai. The network helps show where Xiaotian Dai may publish in the future.

Co-authorship network of co-authors of Xiaotian Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaotian Dai. A scholar is included among the top collaborators of Xiaotian Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaotian Dai. Xiaotian Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 9
5 17
6 74
7 10
8 65
9 3
10 74
11 22
12 24
13 37
14 52
15 6
16 42
17 6
18 20
19
A multi-center study on clinical and etiological diagnosis of chronic cough in Chongqing City.
1
20 1

About Xiaotian Dai

Xiaotian Dai is a scholar working on Molecular Medicine, Geriatrics and Gerontology and Applied Microbiology and Biotechnology, having authored 29 papers that have together received 594 indexed citations. Recurring topics across this work include Neonatal Respiratory Health Research (5 papers), Mesenchymal stem cell research (3 papers) and Sirtuins and Resveratrol in Medicine (3 papers). The work is most often cited by research in Molecular Medicine (96 citations), Geriatrics and Gerontology (54 citations) and Cancer Research (117 citations). Xiaotian Dai has collaborated with scholars based in China, Canada and Pakistan. Frequent co-authors include Zhenghong Lin, Guangjie Duan, Le Yu, Zhaojian Liu, Ling Dong, Haijing Wang, Yongfeng Chen, Liu Liu, Hua Long and Fengjun Sun. Their work appears in journals such as Molecular and Cellular Biology, Oncogene and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026